Differential effects of nebivolol vs. metoprolol on microvascular function in hypertensive humans.

Use of β-adrenergic receptor (AR) blocker is associated with increased risk of fatigue and exercise intolerance. Nebivolol is a newer generation β-blocker, which is thought to avoid this side effect via its vasodilating property. However, the effects of nebivolol on skeletal muscle perfusion during exercise have not been determined in hypertensive patients. Accordingly, we performed contrast-enhanced ultrasound perfusion imaging of the forearm muscles in 25 untreated stage I hypertensive patients at rest and during handgrip exercise at baseline or after 12 wk of treatment with nebivolol (5-20 mg/day) or metoprolol succinate (100-300 mg/day), with a subsequent double crossover for 12 wk. Metoprolol and nebivolol each induced a reduction in the resting blood pressure and heart rate (130.9 ± 2.6/81.7 ± 1.8 vs. 131.6 ± 2.7/80.8 ± 1.5 mmHg and 63 ± 2 vs. 64 ± 2 beats/min) compared with baseline (142.1 ± 2.0/88.7 ± 1.4 mmHg and 75 ± 2 beats/min, respectively, both P < 0.01). Metoprolol significantly attenuated the increase in microvascular blood volume (MBV) during handgrip at 12 and 20 repetitions/min by 50% compared with baseline (mixed-model P < 0.05), which was not observed with nebivolol. Neither metoprolol nor nebivolol affected microvascular flow velocity (MFV). Similarly, metoprolol and nebivolol had no effect on the increase in the conduit brachial artery flow as determined by duplex Doppler ultrasound. Thus our study demonstrated a first direct evidence for metoprolol-induced impairment in the recruitment of microvascular units during exercise in hypertensive humans, which was avoided by nebivolol. This selective reduction in MBV without alteration in MFV by metoprolol suggested impaired vasodilation at the precapillary arteriolar level.

[1]  J. Linden,et al.  Abnormal Regulation of Microvascular Tone in a Murine Model of Sickle Cell Disease Assessed by Contrast Ultrasound. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  M. Gomes,et al.  Antihypertensive Treatment Improves Microvascular Rarefaction and Reactivity in Low‐Risk Hypertensive Individuals , 2013, Microcirculation.

[3]  A. Khera,et al.  Symmetrical Dimethylarginine Predicts Mortality in the General Population: Observations From the Dallas Heart Study , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[4]  B. Adams-Huet,et al.  Differential Effects of Nebivolol Versus Metoprolol on Functional Sympatholysis in Hypertensive Humans , 2013, Hypertension.

[5]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[6]  J. Sowers,et al.  Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat. , 2012, American journal of physiology. Heart and circulatory physiology.

[7]  P. Delafontaine,et al.  The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension. , 2011, Journal of the American Society of Hypertension : JASH.

[8]  J. Mitchell,et al.  Functional sympatholysis is impaired in hypertensive humans , 2011, The Journal of physiology.

[9]  E. Barrett,et al.  Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. , 2011, The Journal of clinical endocrinology and metabolism.

[10]  S. Bangalore,et al.  Cardioprotection with beta‐blockers: myths, facts and Pascal’s wager , 2009, Journal of internal medicine.

[11]  J. Sowers,et al.  Nebivolol Reduces Proteinuria and Renal NADPH Oxidase-Generated Reactive Oxygen Species in the Transgenic Ren2 Rat , 2009, American Journal of Nephrology.

[12]  E. Barrett,et al.  Obesity Blunts Microvascular Recruitment in Human Forearm Muscle After a Mixed Meal , 2009, Diabetes Care.

[13]  C. Mozzini,et al.  Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients. , 2008, American journal of hypertension.

[14]  E. Barrett,et al.  Contraction Stimulates Nitric Oxide–Independent Microvascular Recruitment and Increases Muscle Insulin Uptake , 2007, Diabetes.

[15]  R. Brandes,et al.  Nebivolol Inhibits Superoxide Formation by NADPH Oxidase and Endothelial Dysfunction in Angiotensin II–Treated Rats , 2006, Hypertension.

[16]  Jonathan R Lindner,et al.  Mixed meal and light exercise each recruit muscle capillaries in healthy humans. , 2006, American journal of physiology. Endocrinology and metabolism.

[17]  M. Safar,et al.  Increased skin capillary density in treated essential hypertensive patients. , 2006, American journal of hypertension.

[18]  E. Barrett,et al.  Obesity Blunts Insulin-Mediated Microvascular Recruitment in Human Forearm Muscle , 2006, Diabetes.

[19]  J. Balligand,et al.  Endothelial β3-Adrenoreceptors Mediate Nitric Oxide–Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation β-Blocker Nebivolol , 2005, Circulation.

[20]  D. Brillante,et al.  Effects of Intravenous PD 123319 on Haemodynamic and Arterial Stiffness Indices in Healthy Volunteers , 2005, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[21]  T. LeJemtel,et al.  Endothelial Cell Activation in Patients With Decompensated Heart Failure , 2005, Circulation.

[22]  E. Barrett,et al.  Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. , 2004, Diabetes.

[23]  D. Black,et al.  Change in diet, physical activity, and body weight in female college freshman. , 2004, American journal of health behavior.

[24]  L. Bortel,et al.  Exercise tolerance with nebivolol and atenolol , 1992, Cardiovascular Drugs and Therapy.

[25]  E. Barrett,et al.  Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. , 2003, American journal of physiology. Endocrinology and metabolism.

[26]  J. Banchs,et al.  Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium. , 2002, Journal of applied physiology.

[27]  E. Barrett,et al.  Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. , 2002, Diabetes.

[28]  S. Kaul,et al.  Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. , 2001, Diabetes.

[29]  J. T. ter Maaten,et al.  Impaired Skin Capillary Recruitment in Essential Hypertension Is Caused by Both Functional and Structural Capillary Rarefaction , 2001, Hypertension.

[30]  J. T. ter Maaten,et al.  Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. , 2001, Cardiovascular research.

[31]  C. Yancy,et al.  Noninvasive assessment of hemodynamics: an emphasis on bioimpedance cardiography. , 2000, Current opinion in cardiology.

[32]  R. Victor,et al.  Differential sympathetic neural control of oxygenation in resting and exercising human skeletal muscle. , 1996, The Journal of clinical investigation.

[33]  A. Greene,et al.  Structural Changes During Microvascular Rarefaction in Chronic Hypertension , 1990, Hypertension.

[34]  M. Mikulecký,et al.  Acute haemodynamic effect of metoprolol in essential hypertension. , 1988, Cor et vasa.

[35]  J. Wilmore,et al.  Effects of cardioselective and nonselective beta-adrenergic blockade on the performance of highly trained runners. , 1985, The American journal of cardiology.

[36]  E. Kellerová,et al.  The effect of guanethidine and propranolol on capillary blood flow in subcutaneous tissue and muscle in essential hypertension. , 1974, Cardiology.